Kestra Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Buy
245,693
+7,271
+3% +$697K 0.08% 255
2025
Q4
$22.9M Buy
238,422
+24,691
+12% +$2.4M 0.09% 217
2025
Q3
$20.4M Buy
213,731
+65,827
+45% +$6.05M 0.09% 219
2025
Q2
$12.9M Sell
147,904
-7,090
-5% -$601K 0.06% 310
2025
Q1
$13.9M Buy
154,994
+176
+0.1% +$15.7K 0.07% 261
2024
Q4
$12.4M Sell
154,818
-118,237
-43% -$10.2M 0.07% 303
2024
Q3
$24.6M Buy
273,055
+8,191
+3% +$689K 0.14% 151
2024
Q2
$20.8M Buy
264,864
+116,653
+79% +$9.56M 0.12% 185
2024
Q1
$12.9M Buy
148,211
+21,594
+17% +$1.84M 0.09% 247
2023
Q4
$10.4M Sell
126,617
-9,390
-7% -$716K 0.08% 263
2023
Q3
$10.7M Buy
136,007
+8,352
+7% +$699K 0.1% 221
2023
Q2
$11.2M Buy
127,655
+11,839
+10% +$1.02M 0.11% 206
2023
Q1
$9.34M Sell
115,816
-51,136
-31% -$4.17M 0.1% 221
2022
Q4
$13M Buy
166,952
+39,039
+31% +$3.16M 0.12% 208
2022
Q3
$10.3M Buy
127,913
+13,372
+12% +$1.2M 0.11% 206
2022
Q2
$10.3M Buy
114,541
+22,575
+25% +$2.29M 0.11% 211
2022
Q1
$10.2M Sell
91,966
-6,874
-7% -$726K 0.11% 210
2021
Q4
$10.2M Buy
98,840
+458
+0.5% +$53K 0.1% 221
2021
Q3
$12.3M Buy
98,382
+10,914
+12% +$1.41M 0.12% 184
2021
Q2
$10.9M Sell
87,468
-9,731
-10% -$1.22M 0.12% 190
2021
Q1
$11.5M Buy
97,199
+33,496
+53% +$3.93M 0.15% 166
2020
Q4
$7.37M Buy
63,703
+24,326
+62% +$2.68M 0.09% 256
2020
Q3
$4.09M Buy
+39,377
New +$3.95M 0.08% 273

Other funds holding MDT

Kestra Advisory Services's MDT Position: Q1 2026 in Review

Kestra Advisory Services increased its Medtronic (MDT) stake by 3% in Q1 2026, buying an estimated $697K and bringing the position to 245,693 shares worth $21.3M. The position accounts for 0.08% of the portfolio, ranked #255.

Kestra Advisory Services first reported a position in MDT in Q3 2020 and has held it in 23 quarters since. The position peaked at $24.6M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kestra Advisory Services held 245,693 shares of Medtronic worth $21.3M as of Q1 2026.
  • Kestra Advisory Services bought 7,271 Medtronic shares in Q1 2026, an estimated $697K.
  • Medtronic made up 0.08% of Kestra Advisory Services's portfolio in Q1 2026, its #255 holding.
  • Kestra Advisory Services first reported a position in Medtronic in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Medtronic position peaked at $24.6M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.